Dementia in the News

Time (April 16, 2015): The 100 Most Influential People -- Rudolph Tanzi, PhD

Publication Date: 
Thu, 04/16/2015

Alzheimer's Pioneer (by Maria Shriver)

National Institute on Aging (April 7, 2015): Nations Gather to Coordinate Global Dementia Research

Publication Date: 
Tue, 04/07/2015

NIA Director Dr. Richard J. Hodes joined health ministers, leading scientists, and advocates from around the world March 16-17 in Geneva, Switzerland, to advance dementia research planning on a global scale.

Sing Tao Daily (March 28, 2015); 徐志達醫師談健康養身之道 [Dr. David Hsu Speaks on Ways to Cultivate Good Health]

Publication Date: 
Sat, 03/28/2015

The Sing Dao Daily -- one of the world's widely-read Chinese daily news -- reports on Dr. David Hsu's recent presentation on maintaining good health at the Greater Boston Chinese Golden Age Center!







Boston Globe (March 27, 2015): Researchers Seek to Short-Circuit Alzheimer’s

Publication Date: 
Fri, 03/27/2015

The radio ad pierced Helene DeCoste’s thoughts as she drove home from an exhausting day in Lexington, clearing out mountains of paperwork in her older sister’s house. Bills and documents had piled up as her sister sank into a fog of dementia.

Boston researchers, the radio ad said, sought volunteers to test an Alzheimer’s drug. DeCoste, who watched her mother die of Alzheimer’s and is witnessing the same decline in her 73-year-old sister, dialed the study number soon after she got home.


New York Times (March 25, 2015): In Iceland's DNA, New Clues to Disease-Causing Genes

Publication Date: 
Wed, 03/25/2015

Scientists in Iceland have produced an unprecedented snapshot of a nation’s genetic makeup, discovering a host of previously unknown gene mutations that may play roles in ailments as diverse as Alzheimer’s disease, heart disease and gallstones.

CBS News (March 24, 2015): New Trial to Treat Alzheimer's Seen as "Game Changing"

Publication Date: 
Tue, 03/24/2015

Helene DeCoste of Boston is a patient in a ground breaking clinical trial, testing whether a drug called Solanezumab can slow down or even prevent Alzheimer's disease. No drug has even come close before, but researchers have never tested patients quite like Helene in quite this way before.

"She is a perfect patient for this trial," said Dr. Reisa Sperling, a physician at Harvard University and the project director of what's called the A4 Study.

CBS News (March 23, 2015): Many Alzheimer's Patients Not Told Their Diagnosis

Publication Date: 
Mon, 03/23/2015

Doctors are not telling a majority of their patients diagnosed with Alzheimer's that they have the degenerative brain disease, a new report shows.

The research, conducted by the Alzheimer's Association, involved patients whose Medicare records listed treatments that are specific to Alzheimer's disease.

However, when the researchers asked the patients (or a caregiver as a proxy) if their doctor had informed them that they had the brain-robbing disease, only 45 percent said they had been told so by their doctor.

Harvard Gazette (March 19, 2015): Smarter by the Minute, Sort of

Publication Date: 
Thu, 03/19/2015

New research is changing long-held ideas of how our minds age, painting a richer picture of different cognitive skills peaking across a lifetime, with at least one - vocabulary - peaking at a time when many are considering retirement.

Massachusetts General Hospital (March 17, 2015): MGH Aims to Find Alzheimer’s Disease Cure

Publication Date: 
Tue, 03/17/2015

If you have a friend or loved one who is battling Alzheimer’s disease, you know just how cruel the illness can be. Today, more than 5 million Americans are living with Alzheimer’s, and its rate of diagnosis is increasing as the baby boomer generation ages. Sadly, there is no cure for the disease and no treatments are effective in slowing its progression. But there is hope.

Broad Institute (March 13, 2015): For Drivers of Alzheimer’s Disease, Check the Roadmap

Publication Date: 
Fri, 03/13/2015

Recently, the BroadMinded blog highlighted the exciting science emerging from the Roadmap Epigenomics program, resulting in the most comprehensive map of the human epigenome — the collection of chemical changes to DNA and its supporting proteins that help control how genes are turned on or off.

Syndicate content